Latest & greatest articles for influenza

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on influenza or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on influenza and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for influenza

141. Taiwan's Public Health National Laboratory System: Success in Influenza Diagnosis and Surveillance Full Text available with Trip Pro

Taiwan's Public Health National Laboratory System: Success in Influenza Diagnosis and Surveillance Taiwan's National Laboratory System is one of the action packages of the Global Health Security Agenda, which was launched by the World Health Organization (WHO) to promote health security as an international priority and to encourage progress toward full implementation of the WHO International Health Regulations (IHR) 2005. The mission of each national laboratory system is to conduct real-time (...) laboratory system, Taiwan CDC effectively detects and characterizes pathogens that cause communicable diseases across the entire country, including both known and novel threats, and also conducts epidemiologic analyses of infectious diseases. In this article, we describe the national laboratory system for public health in Taiwan. We provide additional information on the national influenza laboratory surveillance network to demonstrate how our national laboratory systems work in practice, including

2017 Health security

142. Analyzing the clinical profile of swine flu/influenza A H1N1 infection in central India: a retrospective study Full Text available with Trip Pro

Analyzing the clinical profile of swine flu/influenza A H1N1 infection in central India: a retrospective study Recently, India reported an increase in swine flu (influenza A H1N1) activity. There are limited studies on epidemiology of swine flu in Indian context. This study aims to analyze clinical and epidemiological profile of suspected swine flu cases in central India. 171 cases were included in a hospital based, observational, descriptive study conducted from December 2014 to April 2015

2017 Virusdisease

143. Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season – Composition recommandée des vaccins antigrippaux pour la saison grippale 2017-2018 dans l’hémisphère Nord

Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season – Composition recommandée des vaccins antigrippaux pour la saison grippale 2017-2018 dans l’hémisphère Nord Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season – Composition recommandée des vaccins antigrippaux pour la saison grippale 2017-2018 dans l’hémisphère Nord JavaScript is disabled for your browser. Some features (...) of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season – Composition recommandée des vaccins antigrippaux pour la saison grippale 2017-2018 dans l’hémisphère Nord View/ Open View Statistics Altmetrics Share Citation World Health Organization = Organisation mondiale de la Santé . (‎2017)‎. Recommended composition of influenza virus

2017 WHO

144. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 10, March 6 to 12, 2017

Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 10, March 6 to 12, 2017 Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 10, March 6 to 12, 2017 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 10, March 6 to 12, 2017 View/ Open (...) View Statistics Altmetrics Share Other Titles Influenza Bulletin Citation World Health Organization. Regional Office for Africa, Health Emergencies Programme . (‎2017)‎. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 10, March 6 to 12, 2017. Influenza Virological Surveillance, 3 (‎10)‎, 1 - 3. World Health Organization. Regional Office for Africa. Journal Influenza Virological Surveillance, 3 (‎10)‎: 1 - 3 Description 3 p. Collections Language English Metadata

2017 WHO

145. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 11, March 13 to 19, 2017

Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 11, March 13 to 19, 2017 Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 11, March 13 to 19, 2017 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 11, March 13 to 19, 2017 View (...) / Open View Statistics Altmetrics Share Citation World Health Organization. Regional Office for Africa, Health Emergencies Programme . (‎2017)‎. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 11, March 13 to 19, 2017. Influenza Virological Surveillance, 3 (‎11)‎, 1 - 3. World Health Organization. Regional Office for Africa. Journal Influenza Virological Surveillance, 3 (‎11)‎: 1 - 3 Description 3 p. Collections Language English Metadata Related items Showing items

2017 WHO

146. Community-Level Differences in the Microbiome of Healthy Wild Mallards and Those Infected by Influenza A Viruses Full Text available with Trip Pro

Community-Level Differences in the Microbiome of Healthy Wild Mallards and Those Infected by Influenza A Viruses Waterfowl, especially ducks and geese, are primary reservoirs for influenza A viruses (IAVs) that evolve and emerge as important pathogens in domestic animals and humans. In contrast to humans, where IAVs infect the respiratory tract and cause significant morbidity and mortality, IAVs infect the gastrointestinal tract of waterfowl and cause little or no pathology and are spread (...) found that IAV-infected wild mallards exhibited strong differences in microbiome composition relative to noninfected mallards and identified a concise set of putative biomarker OTUs. Using Random Forest, a supervised machine learning method, we verified that these 41 bacterial OTUs are highly predictive of infection status. IMPORTANCE Seasonal influenza causes 3 to 5 million severe illnesses and 250,000 to 500,000 human deaths each year. While pandemic influenza viruses emerge only periodically

2017 mSystems

147. [Economic evaluation of the molecular diagnosis of the influenza virus]

[Economic evaluation of the molecular diagnosis of the influenza virus] Évaluation économique du diagnostic moléculaire du virus influenza [Economic evaluation of the molecular diagnosis of the influenza virus] Évaluation économique du diagnostic moléculaire du virus influenza [Economic evaluation of the molecular diagnosis of the influenza virus] Bélanger S, Martin G Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation (...) of the quality of this assessment has been made for the HTA database. Citation Bélanger S, Martin G. Évaluation économique du diagnostic moléculaire du virus influenza. [Economic evaluation of the molecular diagnosis of the influenza virus] Quebec: Institut national d'excellence en sante et en services sociaux (INESSS). 2016 Authors' conclusions Introducing rapid RT-PCR, in replacement of RDTs and the traditional RT-PCR technique, to diagnose influenza could make tests self-financing and would product

2017 Health Technology Assessment (HTA) Database.

148. Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis Full Text available with Trip Pro

Effect of mass paediatric influenza vaccination on existing influenza vaccination programmes in England and Wales: a modelling and cost-effectiveness analysis In 2013 England and Wales began to fund a live attenuated influenza vaccine programme for individuals aged 2-16 years. Mathematical modelling predicts substantial beneficial herd effects for the entire population as a result of reduced influenza transmission. With a decreased influenza-associated disease burden, existing immunisation (...) programmes might be less cost-effective. The aim of this study was to assess the epidemiological effect and cost-effectiveness of the existing elderly and risk group vaccination programme under the new policy of mass paediatric vaccination in England.For this cost-effectiveness analysis, we used a transmission model of seasonal influenza calibrated to 14 seasons of weekly consultation and virology data in England and Wales. We combined this model with an economic evaluation to calculate the incremental

2017 The Lancet. Public health

149. Cohort study: Inactivated influenza vaccination in first trimester does not appear to increase risk of birth defects

Cohort study: Inactivated influenza vaccination in first trimester does not appear to increase risk of birth defects Inactivated influenza vaccination in first trimester does not appear to increase risk of birth defects | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Inactivated influenza vaccination in first trimester does not appear to increase risk of birth defects Article Text Women’s health and midwifery Cohort study Inactivated influenza

2017 Evidence-Based Nursing

150. Effectiveness of pneumococcal and influenza vaccines to prevent serious health complications in adults with chronic liver disease

Effectiveness of pneumococcal and influenza vaccines to prevent serious health complications in adults with chronic liver disease Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2017 PROSPERO

151. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 29: July 10 to 16 2017

Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 29: July 10 to 16 2017 Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 29: July 17 to 23, 2017 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 29: July 17 to 23, 2017 View/ Open (...) View Statistics Altmetrics Share Citation World Health Organization. Regional Office for Africa, Health Emergencies Programme . (‎2017)‎. Influenza Virological Surveillance in the WHO African Region: Epidemiological Week 29: July 17 to 23, 2017. Influenza Virological Surveillance, 3 (‎29)‎, 1 - 3. World Health Organization. Regional Office for Africa. Journal Influenza Virological Surveillance, 3 (‎29)‎: 1 - 3 Description 3 p. Collections Language English Metadata Related items Showing items

2017 WHO

152. Key elements for the sustainable production of influenza vaccine in Brazil in the framework of the Global Action Plan for Influenza Vaccines

Key elements for the sustainable production of influenza vaccine in Brazil in the framework of the Global Action Plan for Influenza Vaccines Key elements for the sustainable production of influenza vaccine in Brazil in the framework of the Global Action Plan for Influenza Vaccines JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Key elements for the sustainable production (...) of influenza vaccine in Brazil in the framework of the Global Action Plan for Influenza Vaccines View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. Key elements for the sustainable production of influenza vaccine in Brazil in the framework of the Global Action Plan for Influenza Vaccines. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Description 86 p. Gov't Doc # WHO/HIS/TTi/17.1 Collections Language English Metadata Related items Showing items

2017 WHO

153. Made in Viet Nam vaccines: efforts to develop sustainable in-country manufacturing for seasonal and pandemic influenza vaccines: consultation held in Viet Nam, April - June 2016

Made in Viet Nam vaccines: efforts to develop sustainable in-country manufacturing for seasonal and pandemic influenza vaccines: consultation held in Viet Nam, April - June 2016 Made in Viet Nam vaccines: efforts to develop sustainable in-country manufacturing for seasonal and pandemic influenza vaccines: consultation held in Viet Nam, April - June 2016 JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse (...) Statistics Related Links Made in Viet Nam vaccines: efforts to develop sustainable in-country manufacturing for seasonal and pandemic influenza vaccines: consultation held in Viet Nam, April - June 2016 View/ Open Rights View Statistics Altmetrics Share Citation World Health Organization . (‎2017)‎. Made in Viet Nam vaccines: efforts to develop sustainable in-country manufacturing for seasonal and pandemic influenza vaccines: consultation held in Viet Nam, April - June 2016. World Health Organization

2017 WHO

154. Effects of text message reminders on influenza vaccination rate for pregnant women: a systematic review of randomized controlled trials

Effects of text message reminders on influenza vaccination rate for pregnant women: a systematic review of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2017 PROSPERO

155. How do we estimate influenza disease burden in children?ÿ A systematic review

How do we estimate influenza disease burden in children?ÿ A systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2017 PROSPERO

156. Influenza-associated hospitalization and mortality rates among Indigenous and tribal peoples compared to benchmark populations - a systematic review

Influenza-associated hospitalization and mortality rates among Indigenous and tribal peoples compared to benchmark populations - a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2017 PROSPERO

157. Narcolepsy associated with Pandemrix influenza vaccine: a systematic review and meta-analysis

Narcolepsy associated with Pandemrix influenza vaccine: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2017 PROSPERO

158. Effectiveness of seasonal influenza vaccines against laboratory-confirmed influenza: a systematic review and meta-analysis of national and regional influenza surveillance studies

Effectiveness of seasonal influenza vaccines against laboratory-confirmed influenza: a systematic review and meta-analysis of national and regional influenza surveillance studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2017 PROSPERO

159. Influenza vaccination in healthcare workers: a comprehensive critical appraisal of the literature

Influenza vaccination in healthcare workers: a comprehensive critical appraisal of the literature Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address

2017 PROSPERO

160. Influenza Virological Surveillance in the WHO African Region

Influenza Virological Surveillance in the WHO African Region Influenza Virological Surveillance in the WHO African Region JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Influenza Virological Surveillance in the WHO African Region View/ Open View Statistics Altmetrics Share Citation World Health Organization. Regional Office for Africa . (‎2017)‎. Influenza Virological (...) Surveillance in the WHO African Region. Influenza Virological Surveillance, 3 (‎34)‎, 1 - 3. World Health Organization. Regional Office for Africa. Journal Influenza Virological Surveillance, 3 (‎34)‎: 1 - 3 Description 3 p. Collections Language English Metadata Related items Showing items related by title and MeSH subject.  World Health Organization (‎ 2010 )‎  World Health Organization (‎ 2011 )‎  World Health Organization (‎ 2010 )‎ View Item

2017 WHO